Homocystinuria due to cystathionine β‐synthase deficiency: Novel biochemical findings and treatment efficacy
M. Orendáč(The University of Queensland), Viktor Kožich(Charles University), J Zeman(General University Hospital in Prague), Jan P. Kraus(Lexicon Pharmaceuticals (United States)), Sylvia Stöckler‐Ipsiroglu(Vienna General Hospital), Robert H. Allen(Columbia University Irving Medical Center), Sally P. Stabler(University of Colorado Anschutz Medical Campus), Olaf A. Bodamer(Broad Institute), J Kvasnička(Charles University)
Cited by 42
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Homocysteine Metabolism and Risk of Myocardial Infarction: Relation with Vitamins B6, B12, and Folate
|American Journal of Epidemiology|1996|485
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466
Guidelines for the diagnosis and management of cystathionine beta‐synthase deficiency
|Journal of Inherited Metabolic Disease|2016|335